| Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer (NCT00930475) | Charite University, Berlin, Germany | 2009-02-01 |
| Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer (NCT00821886) | SCRI Development Innovations, LLC | 2009-02-01 |
| Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer (NCT00909441) | Centre hospitalier de l'Université de Montréal (CHUM) | 2009-02-01 |
| Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases (NCT01144481) | University Health Network, Toronto | 2009-02-01 |
| Chronic Post Breast Surgery Pain (NCT00847067) | Mayo Clinic | 2009-02-01 |
| Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer (NCT00777335) | Translational Research in Oncology | 2009-02-01 |
| The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer (NCT01023802) | Mayo Clinic | 2009-02-01 |
| Dose-escalation Study of Oral CX-4945 (NCT00891280) | Cylene Pharmaceuticals | 2009-02-01 |
| A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer (NCT00829166) | Hoffmann-La Roche | 2009-02-01 |
| Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00824733) | Bhuvaneswari Ramaswamy | 2009-02-01 |
| Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer (NCT00765765) | University of Medicine and Dentistry of New Jersey | 2009-02-01 |
| Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer (NCT00767520) | Bristol-Myers Squibb | 2009-02-01 |
| Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) (NCT00829959) | M.D. Anderson Cancer Center | 2009-02-01 |
| Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions (NCT00891969) | Rutgers, The State University of New Jersey | 2009-02-01 |
| Mindfulness-Based Stress Reduction (MBSR) Symptom Cluster Trial for Breast Cancer Survivors (NCT01177124) | Cecile Lengacher | 2009-02-01 |
| Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow (NCT00824538) | University of California, San Francisco | 2009-02-01 |
| GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study (NCT00869674) | Johnson & Johnson Medical, China | 2009-02-01 |
| Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer (NCT01227408) | University of Southern California | 2009-02-01 |
| Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer (NCT00896649) | Boston Medical Center | 2009-02-01 |
| Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer (NCT00820872) | Alliance for Clinical Trials in Oncology | 2009-02-01 |
| A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer (NCT00796107) | Hoffmann-La Roche | 2009-01-28 |
| Nipple Sparing Mastectomy - Cosmetic Outcomes (NCT01002014) | Wake Forest University Health Sciences | 2009-01-21 |
| Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS) (NCT00890994) | Mayo Clinic | 2009-01-19 |
| A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine (NCT00833963) | Genentech, Inc. | 2009-01-14 |
| Intellectual Impairment in Women With Breast Cancer (NCT00896324) | Stanford University | 2009-01-12 |
| Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma (NCT00862901) | Tufts Medical Center | 2009-01-01 |
| Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years) (NCT00812864) | University Hospital, Limoges | 2009-01-01 |
| Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? (NCT00766532) | University of Wisconsin, Madison | 2009-01-01 |
| Impact of a Rehabilitation Programme for Mothers With Breast Cancer and Their Children (NCT00916825) | Philipps University Marburg | 2009-01-01 |
| Fatigue in Breast Cancer Survivors (NCT00972400) | St George's, University of London | 2009-01-01 |
| Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients (NCT00952679) | Fudan University | 2009-01-01 |
| Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 (NCT00820170) | Memorial Sloan Kettering Cancer Center | 2009-01-01 |
| Eniluracil Hand Foot Syndrome (NCT00827580) | West Virginia University | 2009-01-01 |
| Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer (NCT01180335) | Gustave Roussy, Cancer Campus, Grand Paris | 2009-01-01 |
| Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors (NCT00877188) | National Taiwan University Hospital | 2009-01-01 |
| A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer (NCT00846027) | Hoffmann-La Roche | 2009-01-01 |
| DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer (NCT02838225) | Peking Union Medical College Hospital | 2009-01-01 |
| Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations (NCT00823654) | Memorial Sloan Kettering Cancer Center | 2009-01-01 |
| S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313 (NCT00949013) | SWOG Cancer Research Network | 2009-01-01 |
| Orthostatic Tolerance in Mamma Cancer Patients After Anaesthesia (NCT00824876) | Rigshospitalet, Denmark | 2009-01-01 |
| Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients (NCT00820547) | UNICANCER | 2009-01-01 |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer (NCT00816244) | Lund University Hospital | 2009-01-01 |
| A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast Cancer (NCT00477139) | Stanford University | 2009-01-01 |
| The Impact of Preoperative Breast MRI in Patients With Breast Cancer Selected for Breast Conserving Surgery (NCT01391806) | Nordlandssykehuset HF | 2009-01-01 |
| Take-Care Program: Effectiveness of a Physical Therapy Program on Cancer Related Symptoms (NCT01274806) | Instituto de Salud Carlos III | 2009-01-01 |
| Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 (NCT00968656) | Washington University School of Medicine | 2009-01-01 |
| Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivors (NCT02940470) | USDA Grand Forks Human Nutrition Research Center | 2009-01-01 |
| Predicting Response to Capecitabine in Women With Metastatic Breast Cancer (NCT00953537) | Centre Antoine Lacassagne | 2009-01-01 |
| A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6 (NCT00900744) | Icahn School of Medicine at Mount Sinai | 2009-01-01 |
| Faslodex Post Marketing Surveillance (NCT00860561) | AstraZeneca | 2009-01-01 |
| Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer (NCT01010854) | University of California, San Francisco | 2008-12-10 |
| Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer (NCT00741260) | Puma Biotechnology, Inc. | 2008-12-09 |
| Liposuction for Arm Lymphedema Following Breast Cancer Surgery (NCT00816985) | H. Lee Moffitt Cancer Center and Research Institute | 2008-12-03 |
| Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer (NCT00810797) | City of Hope Medical Center | 2008-12-02 |
| A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer (NCT00811135) | Hoffmann-La Roche | 2008-12-01 |
| Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients (NCT00896155) | Tata Memorial Hospital | 2008-12-01 |
| S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases (NCT00874211) | SWOG Cancer Research Network | 2008-12-01 |
| Multi-centre Clinical Trial on Hormone Replacement Treatment in China (NCT01698164) | Peking Union Medical College Hospital | 2008-12-01 |
| CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients (NCT00815555) | Assaf-Harofeh Medical Center | 2008-12-01 |
| ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial (NCT00752986) | Genzyme, a Sanofi Company | 2008-12-01 |
| A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine). (NCT00661102) | Hoffmann-La Roche | 2008-12-01 |
| Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer (NCT00847171) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-12-01 |
| Facilitating Adjustment in Low Income Black Women With Breast Cancer (NCT02272335) | University of Miami | 2008-12-01 |
| Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women (NCT00808522) | New York Presbyterian Hospital | 2008-12-01 |
| A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer (NCT00789581) | SCRI Development Innovations, LLC | 2008-12-01 |
| Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients (NCT00817531) | Baylor Breast Care Center | 2008-12-01 |
| Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer (NCT00728442) | Assistance Publique - Hôpitaux de Paris | 2008-12-01 |
| Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon (NCT01333735) | Centre Francois Baclesse | 2008-12-01 |
| Evaluate the Efficacy and Safety of Genexol®-PM Compared to Genexol® in Recurrent or Metastatic Breast Cancer (NCT00876486) | Samyang Biopharmaceuticals Corporation | 2008-12-01 |
| Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer (NCT00949598) | Institut du Cancer de Montpellier - Val d'Aurelle | 2008-12-01 |
| Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer (NCT00760370) | Vejle Hospital | 2008-12-01 |
| Relaxation and Visualization Therapy for Breast Cancer Patients (NCT00691119) | National University of Natural Medicine | 2008-12-01 |
| Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 (NCT00975676) | ETOP IBCSG Partners Foundation | 2008-11-25 |
| A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer (NCT00773695) | Hoffmann-La Roche | 2008-11-07 |
| Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) (NCT00907868) | Institut du Cancer de Montpellier - Val d'Aurelle | 2008-11-01 |
| A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females (NCT00800436) | Hoffmann-La Roche | 2008-11-01 |
| Ultrasound and Mammography for Screening Breast Cancer in Chinese Women (NCT01880853) | Peking Union Medical College Hospital | 2008-11-01 |
| SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy) (NCT01001728) | Royal Marsden NHS Foundation Trust | 2008-11-01 |
| Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients (NCT01068483) | Novartis Pharmaceuticals | 2008-11-01 |
| Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients (NCT00806507) | M.D. Anderson Cancer Center | 2008-11-01 |
| Determination of Predictive Value of Echography Doppler Abnormalities (NCT00714909) | Assistance Publique - Hôpitaux de Paris | 2008-11-01 |
| Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer (NCT00937989) | City of Hope Medical Center | 2008-11-01 |
| H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer (NCT01991340) | Hoffmann-La Roche | 2008-11-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Concurrent Boost Radiotherapy (NCT00981864) | University Health Network, Toronto | 2008-11-01 |
| Walking Affecting Immunology and Quality of Life of Breast Cancer Patients (NCT02581956) | Kaohsiung Veterans General Hospital. | 2008-11-01 |
| Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer (NCT00828074) | City of Hope Medical Center | 2008-11-01 |
| Collection of Raw Data of Thermal Imaging for the Purpose of Developing a Device for Early Detection of Breast Cancer (NCT00750464) | Real Imaging Ltd. | 2008-11-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer (NCT00662129) | Alliance for Clinical Trials in Oncology | 2008-11-01 |
| A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer (NCT01216176) | Joyce Marie Slingerland, MD | 2008-10-21 |
| Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer (NCT00712881) | Cephalon, Inc. | 2008-10-13 |
| Neo-Adjuvant Study in Triple Negative Breast Cancer Patients (NCT01097642) | The Methodist Hospital Research Institute | 2008-10-10 |
| Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer (NCT00667251) | Novartis Pharmaceuticals | 2008-10-07 |
| A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC) (NCT00927511) | Regina Elena Cancer Institute | 2008-10-01 |
| Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer (NCT00691678) | Dawn L. Hershman | 2008-10-01 |
| Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain (NCT01028352) | University of Michigan Rogel Cancer Center | 2008-10-01 |
| Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery. (NCT00777673) | University of Tennessee Cancer Institute | 2008-10-01 |
| Digital Breast Tomosynthesis Preference Study (NCT00776126) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery (NCT00776308) | Mayo Clinic | 2008-10-01 |
| Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery (NCT00801411) | National Cancer Centre, Singapore | 2008-10-01 |